UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A small-molecule inhibitor of BamA impervious to efflux and the outer membrane permeability barrier

Proceedings of the National Academy of Sciences - PNAS, 2019-10, Vol.116 (43), p.21748-21757

2019

Volltextzugriff (PDF)

The pipeline of new molecules and regimens against drug-resistant tuberculosis

Journal of clinical tuberculosis and other mycobacterial diseases, 2021-12, Vol.25, p.100285-100285, Article 100285

2021

Volltextzugriff (PDF)

Temporal Appearance of Plasmid-Mediated Quinolone Resistance Genes

Antimicrobial Agents and Chemotherapy, 2009-04, Vol.53 (4), p.1665-1666

2009

Volltextzugriff (PDF)

Lesions in Teichoic Acid Biosynthesis in Staphylococcus aureus Lead to a Lethal Gain of Function in the Otherwise Dispensable Pathway

Journal of Bacteriology, 2006-06, Vol.188 (12), p.4183-4189

2006

Volltextzugriff (PDF)

Impact of Antifungal Prophylaxis on Colonization and Azole Susceptibility of Candida Species

Antimicrobial Agents and Chemotherapy, 2009-12, Vol.53 (12), p.5026-5034

2009

Volltextzugriff (PDF)

Antibacterial small molecules targeting the conserved TOPRIM domain of DNA gyrase

PloS one, 2017-07, Vol.12 (7), p.e0180965-e0180965

2017

Volltextzugriff (PDF)

Are outer-membrane targets the solution for MDR Gram-negative bacteria?

Drug discovery today, 2021-09, Vol.26 (9), p.2152-2158

2021

Volltextzugriff (PDF)

Discovery of a Novel Class of Orally Active Antifungal β-1,3-d-Glucan Synthase Inhibitors

Antimicrobial Agents and Chemotherapy, 2011-11, Vol.55 (11), p.5099-5106

2011

Volltextzugriff (PDF)

Characterization of Emergent HIV Resistance in Treatment-Naive Subjects Enrolled in a Vicriviroc Phase 2 Trial

The Journal of infectious diseases, 2010-05, Vol.201 (10), p.1470-1480

2010

Volltextzugriff (PDF)

Mapping and characterization of vicriviroc resistance mutations from HIV-1 isolated from treatment-experienced subjects enrolled in a phase II study (VICTOR-E1)

Journal of acquired immune deficiency syndromes (1999), 2011-03, Vol.56 (3), p.222-229

2011

Volltextzugriff (PDF)

Seasonal movements of greater sage-grouse populations in Utah: Implications for species conservation

Wildlife Society bulletin, 2016-06, Vol.40 (2), p.288-299

2016

Volltextzugriff (PDF)

Inhibitor of intramembrane protease RseP blocks the σE response causing lethal accumulation of unfolded outer membrane proteins

Proceedings of the National Academy of Sciences - PNAS, 2018-07, Vol.115 (28), p.E6614-E6621

2018

Volltextzugriff (PDF)

Greater Sage-Grouse and Range Management: Insights from a 25-Year Case Study in Utah and Wyoming

Rangeland ecology & management, 2015-09, Vol.68 (5), p.375-382

2015

Volltextzugriff (PDF)

Genetic strategies for antibacterial drug discovery

Nature reviews. Genetics, 2003-06, Vol.4 (6), p.442-456

2003

Volltextzugriff (PDF)

Evernimicin Binds Exclusively to the 50S Ribosomal Subunit and Inhibits Translation in Cell-Free Systems Derived from both Gram-Positive and Gram-Negative Bacteria

Antimicrobial Agents and Chemotherapy, 2000-05, Vol.44 (5), p.1121-1126

2000

Volltextzugriff (PDF)

Evernimicin (SCH27899) Inhibits a Novel Ribosome Target Site: Analysis of 23S Ribosomal DNA Mutants

Antimicrobial Agents and Chemotherapy, 2000-11, Vol.44 (11), p.3101-3106

2000

Volltextzugriff (PDF)

Mutations in Ribosomal Protein L16 Conferring Reduced Susceptibility to Evernimicin (SCH27899): Implications for Mechanism of Action

Antimicrobial Agents and Chemotherapy, 2000-03, Vol.44 (3), p.732-738

2000

Volltextzugriff (PDF)

Corrigendum to ‘Greater Sage-Grouse and Range Management: Insights from a 25-year Case Study in Utah and Wyoming’[Rangeland Ecol Manag 68 (2015) 375–382]

Rangeland ecology & management, 2016-05, Vol.69 (3), p.235-235

2016

Volltextzugriff (PDF)

SAR studies of pyridazinone derivatives as novel glucan synthase inhibitors

Bioorganic & medicinal chemistry letters, 2011-05, Vol.21 (10), p.2890-2893

2011

Volltextzugriff (PDF)

Effects of Mutations in Ribosomal Protein L16 on Susceptibility and Accumulation of Evernimicin

Antimicrobial Agents and Chemotherapy, 2001-01, Vol.45 (1), p.79-83

2001

Volltextzugriff (PDF)

The synthesis and structure–activity relationship of pyridazinones as glucan synthase inhibitors

Bioorganic & medicinal chemistry letters, 2011-03, Vol.21 (6), p.1819-1822

2011

Volltextzugriff (PDF)

Lead optimization of a sulfonylurea-based piperazine pyridazinone series of glucan synthase inhibitors

Bioorganic & medicinal chemistry letters, 2012-07, Vol.22 (14), p.4896-4899

2012

Volltextzugriff (PDF)

The optimization of pyridazinone series of glucan synthase inhibitors

Bioorganic & medicinal chemistry letters, 2012-08, Vol.22 (16), p.5268-5271

2012

Volltextzugriff (PDF)

Regulation of an Osmoticum-Responsive Gene in Anabaena sp. Strain PCC 7120

Journal of Bacteriology, 1998-12, Vol.180 (23), p.6332-6337

1998

Volltextzugriff (PDF)

1 – 25 von 403

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(344)
Mit Volltextzugriff
(324)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(258)
Life Sciences & Biomedicine
(221)
Humans
(140)
Female
(82)
Male
(81)
Biological And Medical Sciences
(66)
Middle Aged
(63)
Adult
(53)
Medical Sciences
(50)
Neurosciences & Neurology
(46)
Aged
(43)
Physical Sciences
(43)
Animals
(36)
Microbiology
(34)
Chemistry
(31)
Pharmacology & Pharmacy
(30)
Mutation
(29)
Clinical Neurology
(28)
Neurosciences
(28)
Fundamental And Applied Biological Sciences. Psychology
(21)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

A small-molecule inhibitor of BamA impervious to efflux and the outer membrane permeability barrier

The pipeline of new molecules and regimens against drug-resistant tuberculosis

Temporal Appearance of Plasmid-Mediated Quinolone Resistance Genes

Lesions in Teichoic Acid Biosynthesis in Staphylococcus aureus Lead to a Lethal Gain of Function in the Otherwise Dispensable Pathway

Impact of Antifungal Prophylaxis on Colonization and Azole Susceptibility of Candida Species

Antibacterial small molecules targeting the conserved TOPRIM domain of DNA gyrase

Are outer-membrane targets the solution for MDR Gram-negative bacteria?

Discovery of a Novel Class of Orally Active Antifungal β-1,3-d-Glucan Synthase Inhibitors

Characterization of Emergent HIV Resistance in Treatment-Naive Subjects Enrolled in a Vicriviroc Phase 2 Trial

Mapping and characterization of vicriviroc resistance mutations from HIV-1 isolated from treatment-experienced subjects enrolled in a phase II study (VICTOR-E1)

Seasonal movements of greater sage-grouse populations in Utah: Implications for species conservation

Inhibitor of intramembrane protease RseP blocks the σE response causing lethal accumulation of unfolded outer membrane proteins

Greater Sage-Grouse and Range Management: Insights from a 25-Year Case Study in Utah and Wyoming

Genetic strategies for antibacterial drug discovery

Cerastecins inhibit membrane lipooligosaccharide transport in drug-resistant Acinetobacter baumannii

Evernimicin Binds Exclusively to the 50S Ribosomal Subunit and Inhibits Translation in Cell-Free Systems Derived from both Gram-Positive and Gram-Negative Bacteria

Evernimicin (SCH27899) Inhibits a Novel Ribosome Target Site: Analysis of 23S Ribosomal DNA Mutants

Mutations in Ribosomal Protein L16 Conferring Reduced Susceptibility to Evernimicin (SCH27899): Implications for Mechanism of Action

Corrigendum to ‘Greater Sage-Grouse and Range Management: Insights from a 25-year Case Study in Utah and Wyoming’[Rangeland Ecol Manag 68 (2015) 375–382]

SAR studies of pyridazinone derivatives as novel glucan synthase inhibitors

Effects of Mutations in Ribosomal Protein L16 on Susceptibility and Accumulation of Evernimicin

The synthesis and structure–activity relationship of pyridazinones as glucan synthase inhibitors

Lead optimization of a sulfonylurea-based piperazine pyridazinone series of glucan synthase inhibitors

The optimization of pyridazinone series of glucan synthase inhibitors

Regulation of an Osmoticum-Responsive Gene in Anabaena sp. Strain PCC 7120

Suchergebnisse filtern